NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)

CUSIP: 64130M209

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
8,477,622
Total 13F shares
12,450,799
Share change
-1,955,581
Total reported value
$9,437,810
Price per share
$0.76
Number of holders
37
Value change
-$1,624,435
Number of buys
17
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 64130M209?
CUSIP 64130M209 identifies NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bleichroeder LP
13F 13D/G
Company
8%
from 13D/G
4,000,000
$3,554,400 30 Sep 2025
MERCHANT ADVENTURE FUND, L.P.
13D/G
14%
4,200,000
$2,478,000 $0 31 Dec 2024
Sio Capital Management, LLC
13D/G 13F
Company
4.7%
2,360,635
$2,098,132 -$1,033,699 30 Sep 2025
BARD ASSOCIATES INC
13F
Company
22%
1,851,000
$1,644,799 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
19%
1,578,237
$1,403,053 30 Sep 2025
13F
AWM Investment Company, Inc.
13D/G 13F
Company
4.8%
2,354,167
$1,388,959 $0 31 Mar 2025
PERKINS CAPITAL MANAGEMENT INC
13F
Company
17%
1,468,000
$1,304,465 30 Sep 2025
13F
MANCHESTER MANAGEMENT CO LLC
13D/G
JAMES E. BESSER
4.9%
1,583,332
$934,166 $0 31 Dec 2024
Laurence W. Lytton
13D/G
LYTTON LAURENCE W
2.6%
1,295,288
$764,220 $0 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
8.2%
692,600
$615,444 30 Sep 2025
13F
Nantahala Capital Management, LLC
13D/G
2.6%
798,762
$471,270 $0 30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
5.9%
496,834
$441,552 30 Sep 2025
13F
Ronald W. McClurg
3/4/5
Chief Financial Officer
mixed-class rows
694,117
mixed-class rows
$377,588 17 Apr 2025
CITADEL ADVISORS LLC
13F
Company
2.4%
206,277
$183,298 30 Sep 2025
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
1.4%
121,000
$108,000 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
1.3%
112,123
$99,632 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
1.3%
108,297
$96,233 30 Sep 2025
13F
Virtu Financial LLC
13F
Company
1.2%
99,200
$88,000 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.7%
59,499
$52,871 30 Sep 2025
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.66%
55,556
$49,367 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.63%
53,179
$47,255 30 Sep 2025
13F
MAI Capital Management
13F
Company
0.59%
50,000
$44,430 30 Sep 2025
13F
J.W. COLE ADVISORS, INC.
13F
Company
0.44%
37,120
$32,985 30 Sep 2025
13F
Focus Financial Network, Inc.
13F
Company
0.41%
34,722
$30,854 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
0.24%
20,291
$18,031 30 Sep 2025
13F
Princeton Global Asset Management LLC
13F
Company
0.2%
16,833
$14,958 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.15%
12,488
$11,097 30 Sep 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.16%
13,447
$11,000 30 Sep 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.15%
12,357
$10,980 30 Sep 2025
13F
LPL Financial LLC
13F
Company
0.13%
10,934
$9,716 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.12%
10,447
$9,283 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.04%
3,774
$3,354 30 Sep 2025
13F
UBS Group AG
13F
Company
0.02%
1,762
$1,566 30 Sep 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
1,333
$1,185 30 Sep 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
1,259
$956 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
446
$396 30 Sep 2025
13F
Quent Capital, LLC
13F
Company
0%
40
$36 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
20
$18 30 Sep 2025
13F
Vermillion Wealth Management, Inc.
13F
Company
0%
3
$3 30 Sep 2025
13F
Christopher Volker
3/4/5
Chief Operating Officer
class O/S missing
575,000
17 Apr 2025
Emily J. Johns
3/4/5
General Counsel
class O/S missing
500,000
01 Jun 2025

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) as of Q4 2025

As of 31 Dec 2025, NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,450,799 shares. The largest 10 holders included Bleichroeder LP, BARD ASSOCIATES INC, VANGUARD GROUP INC, PERKINS CAPITAL MANAGEMENT INC, Sio Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, Cambridge Investment Research Advisors, Inc., and NORTHERN TRUST CORP. This page lists 37 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
34
Q4 2025 holders
37
Holder diff
3
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .